Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Clinical trial NCT00312286 · TERMINATED

Trial details

NCT number: NCT00312286
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2006-04-01
Primary completion: 2008-06-01
Enrollment: 538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.